Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing ...

Janssen Research & Development was granted FDA orphan designation for a treatment of multiple myeloma, according to a post to the agency’s ...

Researchers at the Icahn School of Medicine at Mount Sinai have discovered how genetics can affect the success of venetoclax, ...

Twin sisters Linda Thomas and Karen Rodman are back home after a kidney transplant from one twin to the other at Cedars-Sinai ...

We recently compiled a list of the 10 Best Up and Coming Stocks To Buy According to Analysts. In this article, we are going ...

Experience convenient blood cancer treatment close to home. Find out how this unique partnership brings autologous stem cell ...

A group in Fayette County is keeping its tradition alive by offering you a chance to win a brand-new Christmas tree for just ...

Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) was downgraded by equities research analysts at Cantor Fitzgerald from a ...

There is more to the comparison, and in the sections below, we discuss why we think BMY will outperform JNJ in the next three ...

Poseida Therapeutics, Inc. (NASDAQ:PSTX – Get Free Report) was the recipient of some unusual options trading on Tuesday. Stock investors acquired 5,174 put options on the company. This represents an ...

In a report released on November 25, Leonid Timashev from RBC Capital maintained a Buy rating on Legend Biotech (LEGN – Research Report), with ...

Around 44,000 people with terminal illnesses will lose the payment, worth up to £300, according to figures obtained by Marie ...